Although mutations in both RB1 alleles appear to be central to retinoblastoma, a small subset of unilateral tumors lack detectable mutations in this gene; instead, they exhibit significantly increased expression of the n-myc proto-oncogene (MYCN—myelocytomatosis-neuroblastoma) [21]. This evidence concerns the gene RB1 and retinoblastoma.